Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions

PURPOSE: To evaluate the bioequivalence and safety of two formulations of 25 mg tenofovir alafenamide tablets in Chinese healthy male and female subjects under fed and fasting conditions. PATIENTS AND METHODS: This was a randomized, open-label, single-center, crossover study consisting of a fasting...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiuying, Jia, Lihui, Hu, Wenli, Dong, Shu, Cai, Chaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215933/
https://www.ncbi.nlm.nih.gov/pubmed/34163141
http://dx.doi.org/10.2147/DDDT.S304108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215933/
https://www.ncbi.nlm.nih.gov/pubmed/34163141
http://dx.doi.org/10.2147/DDDT.S304108

Ejemplares similares